Literature DB >> 18790986

Treatment-related diabetes and cardiovascular disease in prostate cancer survivors.

M R Smith1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18790986      PMCID： PMC2733069          DOI： 10.1093/annonc/mdn458

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  8 in total

1.  Diabetic ketoacidosis with concurrent pancreatitis, pancreatic β islet cell tumor, and adrenal disease in an obese ferret (Mustela putorius furo).

Authors:  Kristen A Phair; James W Carpenter; Thomas Schermerhorn; Chanran K Ganta; Brad M DeBey
Journal:  J Am Assoc Lab Anim Sci       Date:  2011-07       Impact factor: 1.232

2.  LHRH analog therapy is associated with worse metabolic side effects than bilateral orchiectomy in prostate cancer.

Authors:  Andreza Vargas; Roberto Dias Machado; Daniel Ianni Filho; Carlos Eduardo Paiva; Rodolfo Borges Dos Reis; Marcos Tobias-Machado; Eliney Ferreira Faria
Journal:  World J Urol       Date:  2016-04-21       Impact factor: 4.226

Review 3.  Effects of gonadotrophin-releasing hormone outside the hypothalamic-pituitary-reproductive axis.

Authors:  D C Skinner; A J Albertson; A Navratil; A Smith; M Mignot; H Talbott; N Scanlan-Blake
Journal:  J Neuroendocrinol       Date:  2009-03       Impact factor: 3.627

4.  Occurrence of comorbidities among African-American and Latina breast cancer survivors.

Authors:  Kimlin Ashing; Monica Rosales; Lily Lai; Arti Hurria
Journal:  J Cancer Surviv       Date:  2014-01-29       Impact factor: 4.442

5.  Prediagnostic Allostatic Load as a Predictor of Poorly Differentiated and Larger Sized Breast Cancers among Black Women in the Women's Circle of Health Follow-Up Study.

Authors:  Cathleen Y Xing; Michelle Doose; Bo Qin; Yong Lin; Jesse J Plascak; Coral Omene; Chunyan He; Kitaw Demissie; Chi-Chen Hong; Elisa V Bandera; Adana A M Llanos
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-11-12       Impact factor: 4.254

6.  Quantifying the evidence for the risk of metabolic syndrome and its components following androgen deprivation therapy for prostate cancer: a meta-analysis.

Authors:  Cecilia Bosco; Danielle Crawley; Jan Adolfsson; Sarah Rudman; Mieke Van Hemelrijck
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

Review 7.  Metabolic Disorders and Male Hypogonadotropic Hypogonadism.

Authors:  Rosario Pivonello; Davide Menafra; Enrico Riccio; Francesco Garifalos; Marco Mazzella; Cristina de Angelis; Annamaria Colao
Journal:  Front Endocrinol (Lausanne)       Date:  2019-07-25       Impact factor: 5.555

8.  Multiple chronic conditions and associated health care expenses in US adults with cancer: a 2010-2015 Medical Expenditure Panel Survey study.

Authors:  Mary Lynn Davis-Ajami; Zhiqiang K Lu; Jun Wu
Journal:  BMC Health Serv Res       Date:  2019-12-19       Impact factor: 2.655
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.